Skip to main content

Table 1 Baseline characteristics of 85 enrolled patients on whom clinical information was available

From: Sites of colonization in hospitalized patients with infections caused by extended-spectrum beta-lactamase organisms: a prospective cohort study

Variable

Valuea (N = 85)

Age in years, mean ± standard deviation

66.9 ± 15.9

Male gender

33 (38.8)

Comorbid conditions

 Malignancy

41 (48.2)

 Diabetes mellitus

28 (32.9)

 Corticosteroid/Immunosuppressive therapy

22 (25.9)

 Renal insufficiency

11 (12.9)

 Chronic pulmonary disease

8 (9.4)

Exposure to healthcare/invasive devices within 30 days of current infection

 Hospital stay

  0–2 days

50 (58.8)

  3–5 days

12 (14.1)

  > 6 days

23 (27.1)

 Urinary catheter

  0–2 days

69 (81.2)

  3–5 days

7 (8.2)

  > 6 days

9 (10.6)

 Surgical procedure

18 (21.2)

Recent antibiotic use

 Within 24 h prior to enrollment

15 (17.6)

 For >48 h within 30 days prior to enrollment

32 (37.6)

Place of acquisition of infection

 Community-acquired

37 (43.5)

 Healthcare-associated

29 (34.2)

 Hospital-acquired

19 (22.3)

Site of infection

 Urinary tract

74 (87.1)

 Skin and soft tissue

6 (7.1)

 Bloodstream

4 (4.7)

 Respiratory tract

1 (1.2)

  1. aNumbers represent n (%) unless otherwise indicated